Abiopharma

🔍 Watterson Andrew M (Executive)

Company: SOUTHWEST AIRLINES CO (LUV)

Report Date: 2026-03-16

Detailed Transactions and Holdings:

• Acquired 35,092 shares of Common Stock (Direct)
  Date: 2026-03-16 | Code: A | equity_swap_involved: 0 | shares_owned_after: 206,845.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-16 | Code: H | nature_of_ownership: By Retirement Savings Plan | shares_owned_after: 18,105.00 | Footnotes: F2

Footnotes:

• F1: Reflects the exempt acquisition of restricted stock units pursuant to the Southwest Airlines Co. Amended and Restated 2007 Equity Incentive Plan. The restricted stock units will vest with respect to one-third of the shares covered thereby annually, beginning on March 21, 2027, and will entitle the reporting person to one share of common stock for each restricted stock unit that vests.
• F2: Holdings reflect exempt transactions under the Issuer's Retirement Savings Plan.